BRIEF published on 04/02/2025 at 07:35, 1 year 6 months ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
PRESS RELEASE published on 04/02/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 1 year 6 months ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 1 year 7 months ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 7 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 1 year 7 months ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 1 year 7 months ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
Published on 10/20/2026 at 23:10, 1 hour 42 minutes ago Polaris Renewable Energy Awards Key Supply Contract and Issues Notice to Proceed on Punta Lima Battery Storage Investment
Published on 10/20/2026 at 22:00, 2 hours 52 minutes ago Eagle Plains Increases Saskatchewan Royalty Portfolio
Published on 10/20/2026 at 20:10, 4 hours 42 minutes ago Torq Resources Completes Extension of Credit Facility
Published on 10/20/2026 at 17:00, 7 hours 52 minutes ago GameSquare Announces The "Grand Theft Auto" Effect
Published on 10/20/2026 at 14:45, 10 hours 7 minutes ago NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
Published on 10/20/2026 at 23:39, 1 hour 12 minutes ago EQS-Adhoc: NEXTDC Limited: M3 Melbourne Power Delay and Revised FY27 Guidance
Published on 10/20/2026 at 19:32, 5 hours 19 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 5 hours 21 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 5 hours 21 minutes ago Grand City Properties S.A. acquires 20% stake in LEG Immobilien SE to drive strong FFO growth
Published on 10/20/2026 at 19:29, 5 hours 23 minutes ago Aroundtown SA significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:47, 5 hours 5 minutes ago Compagnie Chargeurs Invest becomes Belgrano and reaches a new milestone in the implementation of its public share buyback offer (OPRA)
Published on 10/20/2026 at 12:36, 12 hours 16 minutes ago CNP Assurances announces the signing of a binding agreement with Prudential Financial to acquire its insurance businesses in Brazil and Mexico
